LungRx Inc. (UTHR) and ImmuneWorks Announce Collaboration in Idiopathic Pulmonary Fibrosis and Primary Graft Dysfunction
2/10/2010 8:49:11 AM
More...
|
Aradigm Corporation (ARDM) Completes Study of Inhaled Treprostinil with AERx(R) Inhaler; Lung Rx Makes First Milestone Payment to Aradigm
11/10/2008 8:15:34 AM
More...
|
Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration; First Presentation of Full Data Set from the TRIUMPH-1 Trial of Inhaled Treprostinil
5/22/2008 11:13:16 AM
More...
|
Aradigm Corporation (ARDM) and LungRx Inc. (UTHR) Agree to Develop AERx Essence(R) Technology for Use in Pulmonary Arterial Hypertension
9/5/2007 12:15:14 PM
More...
|
LungRx Inc. (UTHR) TRIUMPH Trial Enrollment to Close
7/11/2007 9:48:43 AM
More...
|
Exclusive License Agreement for Modified Release Beraprost Assumed and Restated by LungRx Inc. (UTHR)
3/28/2007 11:40:58 AM
More...
|
LungRx Inc. (UTHR) Release: Results Of Inhaled Treprostinil Controlled Pilot Studies Reported In The Journal Of The American College Of Cardiology
2/8/2007 12:49:06 PM
More...
|
LungRx Inc. (UTHR) Release: Results Of Inhaled Treprostinil Study Reported In The Journal Of The American College Of Cardiology
10/10/2006 12:45:48 PM
More...
|
LungRx Inc., (UTHR) An Emerging Biotech Now Has The Capabilities Of Large Pharma, Without The Costly Infrastructure And Employees Usually Needed
10/19/2005 5:08:55 PM
More...
|